Mark Mapstone, Ph.D., is a Professor of Neurology at the University of California, Irvine, where he also serves as Vice Chair for Research, Chief of the Neuropsychology Division, Director of the Precision Neurology Program, and Co-Director of the Center for Aging Research in Down Syndrome. A translational neuroscientist with a Ph.D. in clinical psychology from Northwestern University, he focuses on the early detection of Alzheimer’s and Parkinson’s diseases using cognitive phenotyping and blood-based biomarkers. He is a principal investigator of the NIH-funded Alzheimer’s Biomarker Consortium–Down Syndrome and has received an NIH Career Development Award.
